A Glimpse into the Diverse Cellular Immunity against SARS-CoV-2

Area of Science:

• Immunology
• Virology
• Vaccinology

Background:

• Cellular immune responses to SARS-CoV-2 are crucial for preventing severe COVID-19.
• Shared T-cell epitopes across SARS-CoV-2 variants suggest potential for broad-spectrum vaccine strategies.

Purpose of the Study:

• To investigate the potential of targeting multiple SARS-CoV-2 T-cell epitopes for universal protection against viral variants.
• To assess SARS-CoV-2-specific T-cell precursor frequencies in healthy individuals.

Main Methods:

• Utilized overlapping peptide pools from SARS-CoV-2 structural and functional proteins (S, M, E, N, P) to assess T-cell precursors.
• Employed ex vivo dendritic cell (DC)/T cell coculture to induce and confirm anti-SARS-CoV-2 T-cell immune responses.

Main Results:

• Detected diverse SARS-CoV-2-specific T-cell precursor frequencies in healthy individuals, including non-responders.
• The combination of all five viral peptide pools elicited the strongest cellular immune response.
• DC-peptide re-stimulation enhanced anti-viral T-cell responses, even in previously non-responding individuals.

Conclusions:

• A broad anti-SARS-CoV-2 cellular immunity exists, even in immune-naïve populations.
• Antigen-presenting cells can enhance cellular immunity against SARS-CoV-2.
• These findings support the development of vaccines and immunotherapies targeting multiple T-cell epitopes for broad protection against SARS-CoV-2 and its variants.